Bioharvest Sciences Inc (BHST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,641 | -11,135 | -8,931 | -6,418 | -2,338 |
| Depreciation Amortization | 428 | 1,624 | 1,191 | 806 | 399 |
| Accounts receivable | -274 | -1,105 | -628 | -661 | -419 |
| Other Working Capital | 9 | -1,942 | -414 | 354 | 11 |
| Other Operating Activity | 1,099 | 5,332 | 3,808 | 3,036 | 920 |
| Operating Cash Flow | $-1,379 | $-7,226 | $-4,974 | $-2,883 | $-1,427 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -593 | -2,355 | -1,701 | -1,276 | -684 |
| Other Investing Activity | -1,000 | -10 | 4 | 4 | 4 |
| Investing Cash Flow | $-1,593 | $-2,365 | $-1,697 | $-1,272 | $-680 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 12,402 | 10,306 | 5,985 | 3,343 |
| Debt Repayment | N/A | -5,772 | N/A | N/A | N/A |
| Common Stock Issued | N/A | 25,098 | 5,839 | N/A | N/A |
| Other Financing Activity | -840 | -1,541 | -901 | -477 | -221 |
| Financing Cash Flow | $-840 | $30,187 | $15,244 | $5,508 | $3,122 |
| Exchange Rate Effect | -46 | 39 | 3 | -16 | -4 |
| Beginning Cash Position | 23,025 | 2,390 | 2,390 | 2,390 | 2,390 |
| End Cash Position | 19,167 | 23,025 | 10,966 | 3,727 | 3,401 |
| Net Cash Flow | $-3,858 | $20,635 | $8,576 | $1,337 | $1,015 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,379 | -7,226 | -4,974 | -2,883 | -1,427 |
| Capital Expenditure | -593 | -2,355 | -1,701 | -1,276 | -684 |
| Free Cash Flow | -1,972 | -9,581 | -6,675 | -4,159 | -2,111 |